FOXO TECHNOLOGIES INC. Net Income (Loss) Available to Common Stockholders, Basic
FOXO TECHNOLOGIES INC. (FOXO) reported Net Income (Loss) Available to Common Stockholders, Basic of $8.26 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2026-08-14
- FOXO TECHNOLOGIES INC. net income (loss) available to common stockholders, basic for the quarter ending 2026-06-30 was $8.26M.
- FOXO TECHNOLOGIES INC. net income (loss) available to common stockholders, basic for the quarter ending 2026-03-31 was -$1.74M.
- FOXO TECHNOLOGIES INC. net income (loss) available to common stockholders, basic for the quarter ending 2025-12-31 was -$18.69M.
- FOXO TECHNOLOGIES INC. net income (loss) available to common stockholders, basic for the quarter ending 2025-09-30 was -$14.29M.
- FOXO TECHNOLOGIES INC. net income (loss) available to common stockholders, basic for fiscal 2025 was -$35.04M.
- FOXO TECHNOLOGIES INC. net income (loss) available to common stockholders, basic for fiscal 2024 was -$13.56M.
- FOXO TECHNOLOGIES INC. net income (loss) available to common stockholders, basic for fiscal 2023 was -$29.83M.
- FOXO TECHNOLOGIES INC. net income (loss) available to common stockholders, basic for fiscal 2022 was -$95.25M.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 3 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 8 month | Net Income (Loss) Available to Common Stockholders, Basic 8 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 12 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $8.26M 10-Q · filed 2026-08-14 | $6.53M 10-Q · filed 2026-08-14 | -$12.16M derived: sum of 3 quarters · filed 2026-08-14 | -$26.46M derived: sum of 4 quarters · filed 2026-08-14 | ||||||
| 2026-03-31 | -$1.74M 10-Q · filed 2026-05-15 | -$20.43M derived: sum of 2 quarters · filed 2026-05-15 | -$34.72M derived: sum of 3 quarters · filed 2026-05-15 | -$35.67M derived: sum of 4 quarters · filed 2026-08-14 | ||||||
| 2025-12-31 | -$18.69M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | -$32.98M derived: sum of 2 quarters · filed 2026-04-15 | -$33.94M derived: sum of 3 quarters · filed 2026-08-14 | -$35.04M 10-K · filed 2026-04-15 | ||||||
| 2025-09-30 | -$14.29M 10-Q · filed 2025-11-10 | -$15.25M derived: sum of 2 quarters · filed 2026-08-14 | -$16.35M 10-Q · filed 2025-11-10 | -$23.24M derived: sum of 4 quarters · filed 2026-08-14 | ||||||
| 2025-06-30 | -$955.61K 10-Q · filed 2026-08-14 | -$2.06M 10-Q · filed 2026-08-14 | -$8.95M derived: sum of 3 quarters · filed 2026-08-14 | -$10.99M derived: sum of 4 quarters · filed 2026-08-14 | ||||||
| 2025-03-31 | -$1.10M 10-Q · filed 2026-05-15 | -$8.00M derived: sum of 2 quarters · filed 2026-05-15 | -$10.03M derived: sum of 3 quarters · filed 2026-05-15 | -$12.51M derived: sum of 4 quarters · filed 2026-05-15 | ||||||
| 2024-12-31 | -$6.89M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | -$8.93M derived: sum of 2 quarters · filed 2026-04-15 | -$11.40M derived: sum of 3 quarters · filed 2026-04-15 | -$13.56M 10-K · filed 2026-04-15 | ||||||
| 2024-09-30 | -$2.03M 10-Q · filed 2025-11-10 | -$2.03M 10-Q · filed 2024-11-19 | -$4.51M derived: sum of 2 quarters · filed 2025-11-10 | -$6.67M 10-Q · filed 2025-11-10 | -$6.67M 10-Q · filed 2024-11-19 | -$10.53M derived: sum of 4 quarters · filed 2025-11-10 | ||||
| 2024-06-30 | -$2.47M 10-Q · filed 2025-08-19 | -$2.47M 10-Q · filed 2024-08-19 | -$4.63M 10-Q · filed 2025-08-19 | -$4.63M 10-Q · filed 2024-08-19 | -$8.49M derived: sum of 3 quarters · filed 2025-08-19 | -$13.06M derived: sum of 4 quarters · filed 2025-08-19 | ||||
| 2024-03-31 | -$2.16M 10-Q/A · filed 2025-08-19 | -$2.16M 10-Q · filed 2024-06-28 | -$6.02M derived: sum of 2 quarters · filed 2025-08-19 | -$10.59M derived: sum of 3 quarters · filed 2025-08-19 | -$24.35M derived: sum of 4 quarters · filed 2025-08-19 | |||||
| 2023-12-31 | -$3.86M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | -$8.43M derived: sum of 2 quarters · filed 2025-04-15 | -$22.19M derived: sum of 3 quarters · filed 2025-04-15 | -$29.83M 10-K · filed 2025-04-15 | -$29.83M 10-K · filed 2024-06-06 | |||||
| 2023-09-30 | -$4.57M 10-Q · filed 2024-11-19 | -$3.66M 10-Q · filed 2024-01-19 | -$18.33M derived: sum of 2 quarters · filed 2024-11-19 | -$25.97M 10-Q · filed 2024-11-19 | -$25.06M 10-Q · filed 2024-01-19 | -$44.29M derived: sum of 4 quarters · filed 2024-11-19 | ||||
| 2023-06-30 | -$13.76M 10-Q · filed 2024-11-19 | -$21.40M 10-Q · filed 2024-08-19 | -$39.72M derived: sum of 3 quarters · filed 2024-11-19 | -$80.75M derived: sum of 4 quarters · filed 2024-11-19 | ||||||
| 2023-03-31 | -$7.64M 10-Q · filed 2024-11-19 | -$25.96M derived: sum of 2 quarters · filed 2024-11-19 | -$66.99M derived: sum of 3 quarters · filed 2024-11-19 | -$90.53M derived: sum of 4 quarters · filed 2024-11-19 | ||||||
| 2022-12-31 | -$18.32M derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-06-06 | -$59.35M derived: sum of 2 quarters · filed 2024-06-06 | -$82.89M derived: sum of 3 quarters · filed 2024-06-06 | -$95.25M 10-K · filed 2024-06-06 | -$45.44M 10-K · filed 2023-03-31 | |||||
| 2022-09-30 | -$41.03M 10-Q/A · filed 2024-06-04 | -$9.53M 10-Q · filed 2022-11-21 | -$64.56M derived: sum of 2 quarters · filed 2024-06-04 | -$76.93M 10-Q/A · filed 2024-06-04 | -$45.44M 10-Q · filed 2022-11-21 | -$77.81M derived: sum of 4 quarters · filed 2024-06-04 | ||||
| 2022-06-30 | -$23.54M 10-Q · filed 2023-08-10 | -$132.25K 10-Q · filed 2022-08-12 | -$35.91M 10-Q · filed 2023-08-10 | -$509.23K 10-Q · filed 2022-08-12 | -$36.78M derived: sum of 3 quarters · filed 2023-08-10 | -$64.02M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | -$12.37M 10-Q · filed 2023-05-11 | -$376.97K 10-Q · filed 2022-05-16 | -$13.24M derived: sum of 2 quarters · filed 2023-05-11 | -$40.48M derived: sum of 3 quarters · filed 2023-05-11 | -$38.62M derived: sum of 4 quarters · filed 2023-05-11 | |||||
| 2021-12-31 | -$874.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$28.11M derived: sum of 2 quarters · filed 2023-03-31 | -$26.26M derived: sum of 3 quarters · filed 2023-03-31 | -$38.49M 10-K · filed 2023-03-31 | $4.65M 10-K · filed 2022-03-07 | |||||
| 2021-09-30 | -$27.24M 10-Q · filed 2022-11-21 | $367.04K 10-Q · filed 2021-11-15 | -$25.38M derived: sum of 2 quarters · filed 2022-11-21 | -$37.61M 10-Q · filed 2022-11-21 | $3.51M 10-Q · filed 2021-11-15 | |||||
| 2021-06-30 | $1.86M 10-Q · filed 2022-08-12 | $3.14M 10-Q · filed 2022-08-12 | ||||||||
| 2021-03-31 | $5.00M 10-Q · filed 2022-05-16 | |||||||||
| 2020-12-31 | -$1.78M 10-K · filed 2022-03-07 | -$37.71K 10-K · filed 2021-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |